The Use of Biosensor as a New Trend in Cancer:
Bibliometric Analysis from 2007 to 2017
Delfino CSC1,2, Perez Cordovés AI1 and Souza Jr FG1,3*
1 Instituto de Macromoléculas, Centro de Tecnologia-Cidade Universitária, Brasil
2 Faculdade de Farmácia, Centro de Ciências da Saúde-Cidade Universitária, Brasil
3 Programa de Engenharia Civil, Centro de Tecnologia-Cidade Universitária, Brasil
*Corresponding author: Souza Jr FG, Instituto de Macromoléculas, Programa de Engenharia Civil, Centro de Tecnologia-Cidade Universitária, Av.
Horácio Macedo, 2030, Bloco J Universidade Federal do Rio de Janeiro, Brasil
Submission:
June 06, 2018; Published: August 30, 2018
Nanotechnology is a multidisciplinary field that covers large areas of chemistry, physics, and biology as well as engineering. The application
in medicine for diagnosis, prevention, and treatment of diseases, has become known as nanomedicine and is now an excellent tool for new
nanotechnological applications, such as the use of biosensors. This study aimed to analyze bibliometrics related to applications in biosensors and the
relative importance of these publications in cancer. The search base for articles was Google Scholar, due to the higher coverage of articles published in
comparison to other databases of scientific publications, such as Pubmed and Science Direct. The obtained results showed that there was a decrease in
the number of publications referring to cancer at the last decade (2007-2017), but there was an increase in the number of publications regarding the use
of biosensors, showing an interest and tendency using new technologies for clinical diagnosis. Nanotechnology is a promising tool for the development
of new diagnostic methods and its growth for the next decades is undeniable, including biosensors.
Nanotechnology is a multidisciplinary science, encompassing
the areas of engineering, biology, chemistry and physics, being
more and more applied in medicine and pharmacy [1-6].
Nanotechnology’s applications range from drug release studies
to the use of biosensors as a tool for the early diagnosis in several
diseases, as well as the treatment of drugs and antibodies in target
systems in diseases such as cancer [7-10].
Biosensors are small devices that combine a biological
component with a target substrate, which allows for the formation
of the electrochemical signal through a bio-reacquisition reaction,
allowing this signal to be measured through a physical transducer
[7,11-18]. This biomolecular recognition is essential for a biosensor
and, initially, the recognition elements of a biosensor were isolated
from living systems. However, it is now possible to synthesize
these elements in laboratories [19]. Their applications may include
detection of proteins [20-37], viruses [38-56], antibodies [57-74],
DNA [75-89], drugs [90-100], pesticides [101-119] and other low
molecular weight compounds [120-123].
The interest of the use of biosensors for early detection in
cancer using nanotechnology is of great importance for early
clinical diagnosis and consequently to contribute to the reduction
of mortality as well as to the improvement of the quality of life of
the population [124-133].
Cancer is the second leading cause of death worldwide [134-
144]. Thus, the use of biosensors has become a promising tool
for early diagnosis, since the risk of metastasis is a critical point
in the development of the disease, rapidly causing the death
of the individual. Because tumor cells are present at shallow
levels in peripheral blood, they can be detected in patients with
advanced tumors with or without metastasis. Thus, the present
study analyzed bibliometrics related to applications in biosensors
and the relative importance of these publications in cancer. The
obtained results showed that there was a decrease in the number
of publications referring to cancer at the last decade (2007-2017),
but there was an increase in the number of publications regarding
the use of biosensors, showing an interest and tendency using new
technologies for clinical diagnosis
The methodology used in this study was based on the use of
the Google Scholar database for the bibliometrics of scientific
productions. In this database it is possible to have a broader search
of publications, due to the more excellent coverage of journals
Search bases such as Scopus®, Web of Science®, and Compendex®
have their metrics, and when we join these three databases in a
single search, there may be discrepancies in citation numbers, as
well as articles contained in all of them [145]. Google Scholar®
will fetch all articles using the same metric. For the bibliometrics
of scientific productions in the last decade, keywords were used for
the use of biosensors and their applications in cancer in specific
periods from 2007 to 2017. The applications in biosensors used
were diagnostic, bio-detection, biomarker, prevention, biomaterial,
nanoparticles, graphene, tattoos and Point-of-care (POC).
To analyze the impact of nanotechnology with biosensors on
the scientific production of cancer in the last decade, a calculation
was performed aiming to obtain the relative importance based on
the publications of biosensors and their applications in cancer and
the total number of scientific productions in cancer (Table 1).
Table 1: Relative Importance and Tendency in cancer and
biosensors applications.
From the relative importance of publications in biosensors for
each application in cancer followed year by year, a tendency curve
was prepared using an exponential model for a higher sensitivity of
the obtained data, as well as the equation and value of R² (coefficient
of determination) for a better fit of the statistical model. The value
of R²≥0.9 (90%) was used as the reliability criterion of the results
obtained through bibliometrics analysis.
In the last decade, the publications about cancer suffered a
decrease. For instance, 2017 produced around 144K scientific
publications, whereas in 2007 more than 1.1 million publications
were produced. This observed decrease in bibliometrics during the
last decade is shown in Table 2 and Figure 1. Regarding cancer, in
2007, around 0.18% of cancer publications were associated with the
use of biosensors for diagnosis and in 2017, this number increased
to 6.62% of total cancer publications, as shown in Table 3. Figure
2 shows the Tendency Curve for cancer diagnosis, allowing for
inferring an exponential increase with R² equals to 0.9301 (93%).
Table 2:The bibliometrics in cancer (2007-2017).
Table 3:The bibliometrics in biosensor and diagnosis in
câncer (2007-2017).
figure 1:The decrease of publications in cancer (2007-2017).
figure 2:The Relative Importance and Tendency Curve in biosensor and diagnosis in cancer (2007-2017).
figure 3:The increase of publications in biosensor and diagnosis in câncer (2007-2017)
Figure 3 shows the growth in the number of publications
regarding the use of diagnostic biosensors in cancer. In 2007
there were equal to 2.24K publications; in 2017, the number of
publications was of 9.54K. Between 2010 and 2011 there was a
decrease in the number of publications, but after 2012 the growth
of publications took place again, evidencing an interest in research
using biosensors for diagnosis in cancer.
Table 4:The bibliometrics in biosensor and biodetection in
cancer in the last decade.
In cancer, the relative importance of publications in biosensors
and bio-detection was of 0.013% in 2007. Over the past few years,
Relative Importance has increased. In 2017, its approximate value
was 0.47%, showing that research on biosensor tumor markers
using biosensors are increasing. This increase can be observed in
Table 4 and Figure 4. Figure 5 shows the increase in the number
of publications in biodetection in the last decade. The relative
importance of biosensor and biomarker publications in cancer has
increased in the last decade. In 2007, 0.078% of the publications
in tuberculosis were directly related to biosensors and biomarker;
in 2017, this value was of 4.49%. Table 5 and Figure 6 show the
treated data. Figure 7 shows the number of publications in the last
decade of the use of biosensors as a biomarker in cancer.
Table 5:The bibliometrics of biosensor and biomarker in
cancer (2007-2017).
figure 4:The Relative Importance and Tendency Curve in biosensor and biodetection in cancer in the last decade.
figure 5:The bibliometrics of biodetection in cancer using biosensors in the last decade.
figure 6:The Relative Importance and Tendency Curve in biosensor and biomarker in cancer in the last decade
figure 7:The bibliometrics of biosensor and biomarker in cancer in the last decade
The Relative Importance of biosensor publications and cancer
prevention has increased in the last decade. In 2007, 0.11%
of cancer publications were directly related to biosensors and
prevention; in 2017, this value was of 3.86%. Table 6 and Figure 8
show the treated data. Figure 9 shows the number of publications
of biosensor and prevention in cancer in the last decade
Table 6:The bibliometrics of biosensor and prevention of
cancer in the last decade.
figure 8:The Relative Importance and Tendency Curve using biosensor for prevention in cancer in the last decade.
figure 9:The bibliometrics of publications of biosensor and prevention of cancer in the last decade.
figure 10:The Relative Importance and Tendency Curve of biosensor and biomaterial in cancer in the last decade.
Table 7:The bibliometrics of biosensor and biomaterial in
cancer in the last decade.
The relative importance of biosensor and biomaterial
publications in cancer has increased in the last decade. In 2007,
0.11% of cancer publications were directly related to biosensors
and biomaterials; in 2017, this value was of 4.93%. Table 7 shows
these values during the last decade, while Figure 10 presents the
tendency line, the value of R², as well as the Relative Importance.
The number of publications about biosensors and biomaterials
in cancer has increased over the last decade, as can be seen in Figure
11. In 2007, there were 1.39K publications; in 2017, the number
increased reaching 7.10K publications. The relative importance
of publications of biosensors and nanoparticles in cancer has
increased in the last decade. In 2007, 0.13% of cancer publications
were directly related to biosensors and nanoparticles; in 2017,
this value was of 7.77%. Table 8 and Figure 12 show the treated
data. The number of publications on biosensors and nanoparticles
in cancer has increased over the last decade, as can be seen in
Figure 13. In 2007, the number of publications was equal to 1.69K
publications; in 2017, the number reached 11.20K publications.
Table 8:The bibliometrics of biosensors using nanoparticles
in cancer in the last decade.
figure 11:The bibliometrics of biosensor using biomaterial
in cancer in the last decade.
figure 12:The Relative Importance and Tendency Curve
of the biosensor using nanoparticles in cancer in the last
decade.
figure 13:The bibliometrics of biosensor and nanoparticles
in cancer in the last decade.
The relative importance of publications of biosensors and
graphene in cancer has increased in the last decade. In 2007, 0.01%
of cancer publications were directly related to biosensors and
graphene; in 2017, this value was of 3.99%. Table 9 and Figure 14
show the treated data. The Relative Importance of biosensor and
tattoos publications on cancer has increased in the last decade.
In 2007, 0.001% of cancer publications were directly related to
biosensors and tattoos; in 2017, this value was of 0.07%. Table 10
shows these values during the last decade; and in Figure 15 it is
possible to observe the tendency line, the value of R², as well as
the Relative Importance. The number of publications on biosensors
and tattoos in cancer has increased over the last decade, as can be
seen in Figure 16.
figure 14:The Relative Importance and Tendency Curve of biosensors using graphene in cancer in the last decade.
figure 15:The Relative Importance and Tendency Curve of the biosensor used in tattoos in cancer.
figure 16:The bibliometrics of biosensor and tattoos in cancer in the last decade.
Table 9:The bibliometrics of the biosensor using graphene
in cancer in the last decade.
Table 10:The bibliometrics of biosensor using tattoos in
cancer in the last decade.
The relative importance of biosensor and point-of-care (POC)
publications in cancer has increased in the last decade. In 2007,
0.02% of cancer publications were directly related to biosensors
and POCs; in 2017, this value was of 1.77%. Table 11 shows these
values during the last decade; and in Figure 17 it is possible to
observe the tendency line, the value of R², as well as Relative
Importance. The number of publications on biosensors and Pointof-
care in cancer has increased over the last decade, as can be seen
in Figure 18.
Table 11:The bibliometrics of biosensor Point-of-care in
cancer.
figure 17:The Relative Importance and Tendency Curve of
biosensor and Point-of-care in cancer.
figure 18:The bibliometrics of biosensor and Point-of-care in cancer in the last decade.
figure 19:Comparison of the number of biosensor publications in the cancer applications that this study considered
Figure 19 shows a comparison of the number of biosensor
publications in the cancer applications that this study considered.
Despite the more significant number of publications being
diagnosed, it can be observed that the number of publications
in the year 2017 using nanoparticles in cancer was higher than
in diagnosis. The second highest number of applications was
diagnosed, followed by biomaterial, biomarker, prevention,
graphene, point-of-care, bio-detection, and tattoo, respectively.
Some factors may have contributed to the decline of bibliometrics
in cancer. One such factor was the global crisis that occurred in the
period from 2008 to 2013, which directly affected investment in R
& D in several countries around the world, as shown in a study by
OECD [146].
Although the fall in investment may have directly affected cancer
research, it has been observed that concerning nanotechnology, the
bibliometrics in cancer biosensors have increased considerably,
evidencing a trend in new technologies applied to medicine.
Figure 20 shows the values of the relative importance of
biosensor applications in cancer. As can be observed, the use of
nanoparticles in the year 2016 and 2017 has become the largest
of all applications, followed by diagnosis, biomaterial, biomarker,
graphene, prevention, point-of-care, bio-detection, and tattoos. As
it was shown throughout this work, all the curves of tendency had
behavior that corresponds to the increase of the publications using
biosensors in cancer, confirming, thus, a tendency in the use of the
same one.
figure 20:The values of Relative Importance in the last decade of biosensor applications in cancer.
The use of biosensors has been growing over the last decade,
evidencing a search for new applications in it. However, despite
significant budget cuts in R & D, this seems to have not affected the
use of biosensors and their diverse applications in cancer, showing
that the use of technologies applied to health, such as medicine, is a
trend in clinical research.
The authors thank Conselho Nacional de Desenvolvimento
Científico e Tecnológico, Coordenação de Aperfeiçoamento de
Pessoal de Nível Superior (CAPES), Financiadora de Estudos e
Projetos (FINEP PRESAL Ref.1889/10), and Fundação Carlos
Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro
(FAPERJ) for the financial support and scholarships.
Professor, Chief Doctor, Director of Department of Pediatric Surgery, Associate Director of Department of Surgery, Doctoral Supervisor Tongji hospital, Tongji medical college, Huazhong University of Science and Technology
Senior Research Engineer and Professor, Center for Refining and Petrochemicals, Research Institute, King Fahd University of Petroleum and Minerals (KFUPM), Dhahran, Saudi Arabia
Interim Dean, College of Education and Health Sciences, Director of Biomechanics Laboratory, Sport Science Innovation Program, Bridgewater State University